AHEAD THERAPEUTICS SL -  

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 1
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 2.109.650 251.971 1
2018 50.000 0 50.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ANICELLS1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
BIOKIT RESEARCH & DEVELOPMENT SLU1
DRESDEN UNIVERSITY OF TECHNOLOGY1
EUROPEAN HEMATOLOGY ASSOCIATION1
HELMHOLTZZENTRUM DRESDENROSSENDORF EV1
IMMUDEX APS1
INNOVATION ACTA1
KATHOLIEKE UNIVERSITEIT LEUVEN1
ROYAL COLLEGE OF SURGEONS IN IRELAND1
SEMMELWEIS UNIVERSITY OF MEDICINE1
SORBONNE UNIVERSITE1
STICHTING SANQUIN BLOEDVOORZIENING1
UNIVERSITAT AUTONOMA DE BARCELONA1
UNIVERSITEIT ANTWERPEN1
UNIVERSITEIT VAN AMSTERDAM1

Constancy:

Total number of partners: 17
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 17
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-10-01An integrated approach to restore tolerance in autoimmune disease TOLERATEparticipant2.109.65018
2018-12-01Liposome-based Biomimetic Treatment for auto-immune diabetes (T1D) LIPOBITScoordinator50.0001